Dogwood Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DWTX and other ETFs, options, and stocks.About DWTX
Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron.
CEOGregory Duncan
CEOGregory Duncan
Employees12
Employees12
HeadquartersAlpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded2012
Founded2012
Employees12
Employees12
DWTX Key Statistics
Market cap178.07M
Market cap178.07M
Price-Earnings ratio-0.24
Price-Earnings ratio-0.24
Dividend yield—
Dividend yield—
Average volume34.77K
Average volume34.77K
High today$6.08
High today$6.08
Low today$5.93
Low today$5.93
Open price$5.93
Open price$5.93
Volume86.25K
Volume86.25K
52 Week high$29.28
52 Week high$29.28
52 Week low$1.87
52 Week low$1.87
Stock Snapshot
Dogwood Therapeutics(DWTX) stock is priced at $5.98, giving the company a market capitalization of 178.07M. It carries a P/E multiple of -0.24.
As of 2025-12-11, Dogwood Therapeutics(DWTX) stock has fluctuated between $5.93 and $6.08. The current price stands at $5.98, placing the stock +0.8% above today's low and -1.6% off the high.
Dogwood Therapeutics(DWTX) shares are trading with a volume of 86.25K, against a daily average of 34.77K.
During the past year, Dogwood Therapeutics(DWTX) stock moved between $1.87 at its lowest and $29.28 at its peak.
During the past year, Dogwood Therapeutics(DWTX) stock moved between $1.87 at its lowest and $29.28 at its peak.
People also own
Based on the portfolios of people who own DWTX. This list is generated using Robinhood data, and it’s not a recommendation.